Canada

BMI View: Long viewed as a refuge for leading drugmakers, government cost-cutting measures, including the promotion of generics and branded product price reductions, are expected to... 2011-11-21

BMI Core View: Drugmakers based in emerging markets will expand their presence in developed countries. Firms in developing countries enjoy low operating costs but have historically... 2011-11-10

BMI View: While news that Canadian authorities have tightened public drug plans will come as no surprise, reimbursement trends favouring cost-effective studies over clinical success... 2011-10-26

BMI View: While viewed as a positive first step, we do not believe a proposed drug monitoring system will let Canadian drugmakers off the hook from the government's ongoing calls for... 2011-10-18

BMI View: After more than a year of back-door meetings, the ongoing general trade talks between Canada and the European Union could deteriorate if Ottawa resists calls from multinational... 2011-10-04

BMI View: Canadian provinces are finding it increasingly challenging to balance their ideals of universal healthcare with the realities of deteriorating patient care. As private medical... 2011-08-19

BMI View: Faced with low population densities and chronic shortages of doctors, Canadian provinces present lucrative opportunities for providers of remote healthcare technologies. We... 2011-08-04